You are here

  • Home
  • Archive
  • Volume 32, Issue 6
  • Stereotactic body radiotherapy in oligometastatic cervical cancer (MITO-RT2/RAD study): a collaboration of MITO, AIRO GYN, and MaNGO groups

Article metrics

Article menu
Download PDFPDF
Original research
Stereotactic body radiotherapy in oligometastatic cervical cancer (MITO-RT2/RAD study): a collaboration of MITO, AIRO GYN, and MaNGO groups

 

Online download statistics by month:

Online download statistics by month: March 2022 to March 2023

AbstractFullPdf
Feb 20223831110
Mar 20223581311
Apr 202215765
May 2022172117
Jun 20229003526
Jul 20223212221
Aug 202213677
Sep 202213594
Oct 202219285
Nov 20224261321
Dec 202237254
Jan 202315043
Feb 202318944
Mar 202311023
Total4001150131